Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1995 Feb;39(2):211.

Protein binding of warfarin.

G Levy
PMCID: PMC1364966  PMID: 7742167

Full text

PDF

Page 211

211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chan E., McLachlan A. J., Pegg M., MacKay A. D., Cole R. B., Rowland M. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Br J Clin Pharmacol. 1994 Jun;37(6):563–569. doi: 10.1111/j.1365-2125.1994.tb04305.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Yacobi A., Levy G. Importance of assay specificity for plasma protein binding determinations. J Pharmacokinet Biopharm. 1975 Dec;3(6):439–441. doi: 10.1007/BF01059475. [DOI] [PubMed] [Google Scholar]
  3. Yacobi A., Stoll R. G., DiSanto A. R., Levy G. Intersubject variation of warfarin binding to protein in serum of normal subjects. Res Commun Chem Pathol Pharmacol. 1976 Aug;14(4):743–746. [PubMed] [Google Scholar]
  4. Yacobi A., Udall J. A., Levy G. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):552–558. doi: 10.1002/cpt1976195part1552. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES